---
title: "Akari Therapeutics Plc — Ownership Dossier"
canonical: https://whiteintel.dev/entity/2b19d013-cda4-53fc-825b-58822ac0d1a8
json: https://whiteintel.dev/api/public/dossier/2b19d013-cda4-53fc-825b-58822ac0d1a8
identifier: sec:0001541157
jurisdiction: US
risk: High
source: WhiteIntel corporate-ownership graph
---

# Akari Therapeutics Plc

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001541157`  
**Risk level:** High  
**Canonical dossier:** https://whiteintel.dev/entity/2b19d013-cda4-53fc-825b-58822ac0d1a8  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/2b19d013-cda4-53fc-825b-58822ac0d1a8  

## Ownership & control

### Owners / controllers

- **Huh Hoyoung** (10% owner) — https://whiteintel.dev/entity/3e87c78b-15f6-5ed5-8241-724878024eea
- **Huh Hoyoung** (10% owner) — https://whiteintel.dev/entity/3e87c78b-15f6-5ed5-8241-724878024eea
- **Huh Hoyoung** (tenpercentowner) — https://whiteintel.dev/entity/3e87c78b-15f6-5ed5-8241-724878024eea
- **Patel Samir Rashmikant** (tenpercentowner) — https://whiteintel.dev/entity/1eedb926-51fe-5508-8c4c-c8f4b7758a86
- **RPC PHARMA LTD** (tenpercentowner) — https://whiteintel.dev/entity/0fce285e-7ebb-5497-bb22-c6c7fb77cbf0
- **Prudo-Chlebosz Raymond** (tenpercentowner) — https://whiteintel.dev/entity/a9669fb4-2101-5066-8173-d208114270fe
- **UNGAR STUART** (tenpercentowner) — https://whiteintel.dev/entity/0050ccdb-b052-524a-ab0e-6f42017ec739
- **HILL JAMES** (tenpercentowner) — https://whiteintel.dev/entity/43d8a9c6-5a1b-531c-9afc-e38d8a0dc09d
- **MINTZ HAL** (tenpercentowner) — https://whiteintel.dev/entity/3ab63787-6250-5476-820c-096c0dcccfee
- **SABBY MANAGEMENT, LLC** (tenpercentowner) — https://whiteintel.dev/entity/5b047b80-8260-550e-a586-9e62f498aa91
- **SABBY HEALTHCARE MASTER FUND, LTD.** (tenpercentowner) — https://whiteintel.dev/entity/dfef00d1-94be-5a48-9ae2-079d7e1da8aa

### UBO chain (walk to the ultimate owner)

A **62-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **Akari Therapeutics Plc** — https://whiteintel.dev/entity/2b19d013-cda4-53fc-825b-58822ac0d1a8 · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Akari Therapeutics Plc**. Human view: https://whiteintel.dev/entity/2b19d013-cda4-53fc-825b-58822ac0d1a8 · Structured JSON: https://whiteintel.dev/api/public/dossier/2b19d013-cda4-53fc-825b-58822ac0d1a8._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._